首页> 外文期刊>Journal of nanoscience and nanotechnology >Targeted Therapeutic Effect of Bavachinin Nanospheres on Pathological Site of Chronic Asthmatic Mice Model
【24h】

Targeted Therapeutic Effect of Bavachinin Nanospheres on Pathological Site of Chronic Asthmatic Mice Model

机译:Bavachinin纳米球对慢性哮喘小鼠模型病理遗址的靶向治疗作用

获取原文
获取原文并翻译 | 示例
           

摘要

Steroids are the main drugs currently used to treat asthma. However, the toxic and side effects of these drugs and the tolerance of the drugs due to long-term administration are still problems in the clinical treatment of asthma. Bavachinin has a good effect in the treatment of mouseasthma models, and it can effectively inhibit the expression of a variety of cytokines. However, it is extremely difficult to dissolve in water, has low bioavailability, and is quickly cleared in the blood. These characteristics limit its clinical application potential. In this study, nanotechnologywas used to construct an effective oral drug delivery system. Through analysis of serum-related antibodies and cytokines, the system showed significant therapeutic effects on asthma-positive groups. Far-infrared imaging results showed that the system has a good targeted enrichment effect onpathological parts, while showing lower toxicity and higher therapeutic effect. Whether it is the splenocyte flow typing or the analysis of lung tissue, the system has verified the excellent treatment, and through the observation of paraffin sections of lung tissue, it was found that the bronchialmorphology returned to normal after drug treatment, and the leakage of inflammatory cells was significantly reduced.
机译:类固醇是目前治疗哮喘的主要药物。然而,这些药物的毒副作用以及长期给药的耐受性仍然是哮喘临床治疗中的问题。巴伐他汀对小鼠哮喘模型有良好的治疗作用,能有效抑制多种细胞因子的表达。然而,它极难溶于水,生物利用度低,在血液中很快被清除。这些特点限制了其临床应用潜力。在这项研究中,纳米技术被用于构建有效的口服给药系统。通过对血清相关抗体和细胞因子的分析,该系统对哮喘阳性组显示出显著的治疗效果。远红外成像结果表明,该系统对病变部位具有良好的靶向富集效果,同时显示出较低的毒性和较高的治疗效果。无论是脾细胞流分型还是肺组织分析,该系统都验证了该疗法的优越性,通过对肺组织石蜡切片的观察,发现药物治疗后支气管形态恢复正常,炎性细胞渗漏明显减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号